GiveBetter x New York City

Northern Manhattan Perinatal Partnership

Whole recipient; maternal, infant and early-childhood health scenario

Research time: ~5 min on GPT-6 Astra Light + ~2 min on GPT-6.1 Sol
  • Research — reviewed programs, finances and impact evidence.
  • Source audit — checked claims, assumptions and calculations.
  • Modeling — estimated costs, QALYs and uncertainty.

Updated: 2026-10-07

Donate

Summary

What do they do? NMPP supports families through perinatal case management, home visiting, doula care, clinical partnerships and early-childhood education. The modeled health pathways include maternal well-being, nonfatal infant morbidity, rare infant deaths and modest early-childhood health gains. All recipient operating costs remain in the denominator, with explicit overlap, public-funding and geographic adjustments.

Why we’re interested in this organization:

  • Primary reports document substantial ongoing perinatal and early-childhood services.

  • Independent research supports several mechanisms, while current city audit evidence identifies delivery barriers.

  • The model addresses material family-health pathways without converting every referral or birth into an outcome.

Our main reservations:

  • Cohort overlap and the number of births actually exposed to intensive care are not directly measured.

  • Rare-event, utility and donor-response inputs are explicit judgments.

  • FY2024 is available only as a later-return comparative, not independently verified gross accounts.

What do you get for your dollar? $6.6M per DALY in New York City. DALY is our one-year comparison unit. QALY-based health gains and income-welfare equivalents retain their original assumptions; they are not measured clinical DALYs. Retained family clinical reference; household childcare/work resources assessed unknown.

Additional coordinated prenatal/postpartum and family services -> fewer nonfatal infant conditions and rare deaths, maternal symptoms improved, modest child-health gains -> finite QALYs.

1. What do they do?

NMPP, EIN 13-3782555, is the whole charitable recipient, including Head Start/Pre-K, Healthy Families, PICHC, Healthy Journey, doula care, pediatric and obstetric community-health workers, workforce and advocacy activities. Healthy Journey focuses on Harlem ZIP codes and also serves displaced families. Hospital partnerships may serve residents beyond those ZIP codes. Current program scope

2. Monitoring and information sharing

The original 2024 report's charts show 210 PICHC clients and 93 births, 242 Healthy Journey clients and 83 Healthy Families families. It separately reports 90 postpartum-doula enrollments, 117 obstetric-CHW enrollments and 185 Head Start students. These are not disjoint unique people. The model applies an explicit overlap adjustment to the five maternal/family program counts and uses a separate assumed annual birth cohort; it does not sum every referral, visit or doula trainee. Original report

The city's 2025 doula audit found favorable aggregate comparisons but no randomized local effect, fragmented data and inconsistent shelter access. Those limitations matter for precisely the families NMPP aims to reach. The sepsis partnership paper describes community-centered research, not demonstrated deaths prevented. Neither historical paid-leave enactment nor all future sepsis gains is awarded to a new gift. City audit Sepsis research

3. Qualitative assessment

Maternal and infant health is the most plausible severe-outcome pathway, but the estimate also recognizes Head Start's substantial recipient cost and potential short-term child health contribution. A New York randomized home-visiting study found low-birth-weight rates of 5.1% versus 9.8%; it was an older selected prenatal subgroup, not an NMPP evaluation. Labor-support trials support some delivery outcomes but do not establish a large infant-mortality effect. Low birth weight is a risk marker, not itself a QALY count. Home-visiting trial Labor-support review

The numerical model therefore uses much smaller explicit net clinical priors rather than importing the trial's full birth-weight difference. Early-childhood benefits are modest and short-lived in the central case; long-run educational, income, parenting, community and policy effects remain unpriced. Head Start evidence does not justify assigning each student a lifetime health gain. Head Start follow-up

Household childcare and work resources are assessed unknown, not zero or a90%-health finding.

4. What do you get for your dollar?

Signed household resources are assessed unknown and potentially material. The retained conditional family-health reference remains about $6.6M per DALY, with 1.136523947818204 MSA QALYs at $7,445,700 of full annual recipient expense. It is not a complete combined valuation, zero-income finding or empirical90%-health share. All seven original worlds remain unchanged.

The current Head Start page describes five-day, full-day preschool with meals and contracted capacity for200 children. This is an operational care pathway, not200 new gift-caused households; the historical185 students remain unchanged in the clinical diagnostic. Actual class hours cannot be inferred from office opening hours. Care may displace paid childcare or food purchases and enable parent work, but existing free UPK/Head Start or unpaid family care are important alternatives. Child counts require resource-sharing household deduplication.

Healthy Journey supplies family and perinatal service mechanisms. Harlem Works identifies job-readiness/training workshops, not paid placement or causal net wages. A numerical bridge needs current gift-responsive participation beyond funded contracts, actual alternative private payments and additional work after taxes, benefits withdrawn, commuting and childcare costs, full access/admin/time burdens, MSA residence and finite care duration/delay. Childcare savings and care-enabled work must be jointly accounted, not added as overlapping gross gains.

Full incurred negative costs cannot depend on clinical response; positive overlap applies only to gains. Public/provider resources and financing transfers require separate scope without duplicating original clinical or resource-cost diagnostics. Wider family and workforce effects remain unquantified, not zero; no retail preschool/meal value, child lifetime wages or ordinary survivor earnings is credited.

The conditional family-health price is approximately $6.6M per DALY.

The whole-recipient annual cost is $7,445,700. The five overlapping maternal/family program counts sum to 742 service slots; a subjective 60% unique-person factor produces 445.2 modeled family-care participants. A separately assumed 250 births spans the multiple prenatal programs without counting all family-service recipients as current births. This is not an observed unique birth total.

The central clinical priors are: 0.01 fewer nonfatal infant-morbidity cases per supported birth, with 0.1 utility gain waning at 0.2 annually for at most three years; 0.0001 fewer infant deaths per birth, valued with a 30-year cap, 0.9 utility and 0.005 competing mortality; a 0.04 maternal symptom-response probability with 0.2 utility gain for at most one year; and a 0.005 average child-health utility gain for 185 Head Start students for at most one year. These are judgment-based native health outcomes, not observed program effects or a claim that birth-weight improvement causes all these gains.

Infant nonfatal morbidity and infant survival terms are mutually exclusive outcome channels; the morbidity term has no additional mortality value. Maternal and preschool benefits concern different people. A 50% alternative-service adjustment and 50% ordinary funding response are applied once to the combined health total. The local share is 98%, with lower shares tested for hospital referrals and displacement outside the MSA. Complete replacement and a net-harm case are retained. Added clinical/partner costs and unrecognized volunteer resources are explicit sensitivities. This is a broad conditional family-health scenario, not measured total portfolio return.

Model, assumptions and sensitivity

Entire FY2025 gross recipient cost; no Head Start or administrative exclusion. External clinical and unrecognized-resource costs tested separately.

98% modeled MSA share is a judgment reflecting Harlem/NYC focus with referral and displacement uncertainty, not an exact patient-residence census.

k=ln(1+d); F(r,t)=(1-exp(-(r+k)*t))/(r+k); Qall=a*b*[B*(ri*ui*F(rhoi,ti)+rd*ud*F(md,td))+S*o*pm*um*F(rhom,tm)+K*uk*F(0,tk)]-h; QMSA=g*Qall; price10=10*C/QMSA if positive.

C
7445700 USD annual whole-recipient expense (observed). Full FY2025 original audited expense. [audit2025] [return2025]
S
742 reported overlapping maternal/family program slots (observed). 210+242+83+90+117 reported program slots; not unique people. [impact]
o
0.6 unique-person fraction (judgment). Explicit prior, not an observed NMPP clinical effect or source-calibrated probability. [impact]
B
250 assumed annual supported births (judgment). Explicit prior, not an observed NMPP clinical effect or source-calibrated probability. [impact]
K
185 Head Start students (observed). 185 students in original 2024 report. [impact]
ri
0.01 nonfatal infant morbidity cases prevented per birth (judgment). Explicit prior, not an observed NMPP clinical effect or source-calibrated probability. [homevisit] [doula] [headstart] [cityaudit]
ui
0.1 utility gain per nonfatal infant case (judgment). Explicit prior, not an observed NMPP clinical effect or source-calibrated probability. [homevisit] [doula] [headstart] [cityaudit]
ti
3 maximum morbidity-benefit years (judgment). Explicit prior, not an observed NMPP clinical effect or source-calibrated probability. [homevisit] [doula] [headstart] [cityaudit]
rhoi
0.2 annual morbidity-effect waning (judgment). Explicit prior, not an observed NMPP clinical effect or source-calibrated probability. [homevisit] [doula] [headstart] [cityaudit]
rd
0.0001 infant deaths prevented per birth (judgment). Explicit prior, not an observed NMPP clinical effect or source-calibrated probability. [homevisit] [doula] [headstart] [cityaudit]
ud
0.9 survival utility (judgment). Explicit prior, not an observed NMPP clinical effect or source-calibrated probability. [homevisit] [doula] [headstart] [cityaudit]
md
0.005 annual competing mortality hazard (judgment). Explicit prior, not an observed NMPP clinical effect or source-calibrated probability. [homevisit] [doula] [headstart] [cityaudit]
td
30 maximum survival years (judgment). Explicit prior, not an observed NMPP clinical effect or source-calibrated probability. [homevisit] [doula] [headstart] [cityaudit]
pm
0.04 incremental maternal symptom-response probability difference versus baseline (judgment). Explicit prior, not an observed NMPP clinical effect or source-calibrated probability. [homevisit] [doula] [headstart] [cityaudit]
um
0.2 maternal utility gain (judgment). Explicit prior, not an observed NMPP clinical effect or source-calibrated probability. [homevisit] [doula] [headstart] [cityaudit]
tm
1 maximum maternal benefit years (judgment). Explicit prior, not an observed NMPP clinical effect or source-calibrated probability. [homevisit] [doula] [headstart] [cityaudit]
rhom
0.5 annual maternal-effect waning (judgment). Explicit prior, not an observed NMPP clinical effect or source-calibrated probability. [homevisit] [doula] [headstart] [cityaudit]
uk
0.005 average preschool health utility gain (judgment). Explicit prior, not an observed NMPP clinical effect or source-calibrated probability. [homevisit] [doula] [headstart] [cityaudit]
tk
1 maximum preschool benefit years (judgment). Explicit prior, not an observed NMPP clinical effect or source-calibrated probability. [homevisit] [doula] [headstart] [cityaudit]
a
0.5 service additionality (judgment). Explicit prior, not an observed NMPP clinical effect or source-calibrated probability. [homevisit] [doula] [headstart] [cityaudit]
b
0.5 funding response (judgment). Explicit prior, not an observed NMPP clinical effect or source-calibrated probability. [homevisit] [doula] [headstart] [cityaudit]
g
0.98 MSA fraction (judgment). Explicit prior, not an observed NMPP clinical effect or source-calibrated probability. [homevisit] [doula] [headstart] [cityaudit]
h
0.00 net adverse QALYs (judgment). Explicit prior, not an observed NMPP clinical effect or source-calibrated probability. [homevisit] [doula] [headstart] [cityaudit]
d
0.03 annual discount rate (judgment). Explicit prior, not an observed NMPP clinical effect or source-calibrated probability. [homevisit] [doula] [headstart] [cityaudit]

Conditional broad family-health scenario: Cost: $7.4M; New York City health QALYs: 1.14; all-population health QALYs: 1.16. {"C":7445700,"S":742,"o":0.6,"B":250,"K":185,"ri":0.01,"ui":0.1,"ti":3,"rhoi":0.2,"rd":0.0001,"ud":0.9,"md":0.005,"td":30,"pm":0.04,"um":0.2,"tm":1,"rhom":0.5,"uk":0.005,"tk":1,"a":0.5,"b":0.5,"g":0.98,"h":0,"d":0.03}

Weak clinical effect and substantial substitution: Cost: $7.4M; New York City health QALYs: 0.02; all-population health QALYs: 0.02. {"C":7445700,"S":742,"o":0.4,"B":150,"K":185,"ri":0.002,"ui":0.1,"ti":3,"rhoi":0.2,"rd":0.00001,"ud":0.9,"md":0.005,"td":10,"pm":0.01,"um":0.2,"tm":1,"rhom":0.5,"uk":0.001,"tk":1,"a":0.25,"b":0.1,"g":0.9,"h":0,"d":0.03}

Stronger integrated perinatal and child-health gains: Cost: $7.4M; New York City health QALYs: 12.90; all-population health QALYs: 13.16. {"C":7445700,"S":742,"o":0.8,"B":350,"K":185,"ri":0.025,"ui":0.1,"ti":5,"rhoi":0.2,"rd":0.0005,"ud":0.9,"md":0.005,"td":40,"pm":0.1,"um":0.2,"tm":2,"rhom":0.5,"uk":0.015,"tk":1,"a":0.75,"b":0.75,"g":0.98,"h":0,"d":0.03}

Complete funding replacement: Cost: $7.4M; New York City health QALYs: 0.00; all-population health QALYs: 0.00. {"C":7445700,"S":742,"o":0.6,"B":250,"K":185,"ri":0.01,"ui":0.1,"ti":3,"rhoi":0.2,"rd":0.0001,"ud":0.9,"md":0.005,"td":30,"pm":0.04,"um":0.2,"tm":1,"rhom":0.5,"uk":0.005,"tk":1,"a":0.5,"b":0,"g":0.98,"h":0,"d":0.03}

No health improvement with one QALY of net harm: Cost: $7.4M; New York City health QALYs: -0.98; all-population health QALYs: -1.00. {"C":7445700,"S":742,"o":0.6,"B":250,"K":185,"ri":0,"ui":0.1,"ti":3,"rhoi":0.2,"rd":0,"ud":0.9,"md":0.005,"td":30,"pm":0,"um":0.2,"tm":1,"rhom":0.5,"uk":0,"tk":1,"a":0.5,"b":0.5,"g":0.98,"h":1,"d":0.03}

Added partner clinical resources: Cost: $7.8M; New York City health QALYs: 1.14; all-population health QALYs: 1.16. {"C":7758200,"S":742,"o":0.6,"B":250,"K":185,"ri":0.01,"ui":0.1,"ti":3,"rhoi":0.2,"rd":0.0001,"ud":0.9,"md":0.005,"td":30,"pm":0.04,"um":0.2,"tm":1,"rhom":0.5,"uk":0.005,"tk":1,"a":0.5,"b":0.5,"g":0.98,"h":0,"d":0.03}

Unrecognized resource cost 25%: Cost: $9.3M; New York City health QALYs: 1.14; all-population health QALYs: 1.16. {"C":9307125,"S":742,"o":0.6,"B":250,"K":185,"ri":0.01,"ui":0.1,"ti":3,"rhoi":0.2,"rd":0.0001,"ud":0.9,"md":0.005,"td":30,"pm":0.04,"um":0.2,"tm":1,"rhom":0.5,"uk":0.005,"tk":1,"a":0.5,"b":0.5,"g":0.98,"h":0,"d":0.03}

Combined resources unknown; clinical reference retained: Cost: $7.4M; New York City health QALYs: 1.14; all-population health QALYs: 1.16. Original clinical model and full annual recipient scope retained; net household resources unknown, not zero.

Counterfactual: Existing Medicaid, public home visiting and childcare, hospital care, other doula providers and enacted paid prenatal leave continue. a discounts service replacement; b discounts ordinary-donation effects once.

Attribution: Overlapping maternal/family counts are reduced by o; B is an explicit unique-birth hypothesis, not a program-count sum. Nonfatal infant, infant survival, maternal and preschool health channels are separated and finite.

Source-grounded scale with explicit subjective clinical priors, not a statistically calibrated causal forecast. Major long-term social and policy effects remain incomplete; zero and adverse outcomes are retained.

Sensitivity

  • Weak clinical effect and substantial substitution: 4598589522 USD per DALY.
  • Stronger integrated perinatal and child-health gains: 5773482 USD per DALY.
  • Complete funding replacement: no finite positive-benefit price.
  • No health improvement with one QALY of net harm: no finite positive-benefit price.
  • Added partner clinical resources: 68262530 USD per DALY.
  • Unrecognized resource cost 25%: 81891147 USD per DALY.

Unresolved inputs

  • Current deduplicated family and birth cohorts across all programs.
  • Comparative severe morbidity, infant mortality and maternal symptom outcomes.
  • Effect of ordinary gifts on staffing and services under existing public contracts.
  • Original FY2024 gross financial statements and restricted-balance reconciliation.
  • External clinical costs and long-term Head Start, sepsis and policy outcomes.
  • Deduplicated current funded/additional childcare and family households, actual paid-care/food alternatives and retained net work resources, taxes/benefit effects and full access/time costs, gift-responsive capacity beyond contracts/free public programs, MSA residence and finite duration/delay.

5. Funding and previous grants

The original return ending June 30, 2025 and the current original audit agree on $7,445,700 total expense, including all programs and administration, with no separately netted event cost. The audit recognizes $146,554 in-kind revenue within its accounts; it is not added again. A $152,615 prior-period adjustment reduces net assets and is not classified as new annual operating expense. FY2023 original full-year expense is $6,974,520. FY2024's $7,162,212 appears only as the FY2025 return's comparative: it is marked noncomparable pending its original gross reconciliation. The older FY2022 return covers only January–June and is not annualized into this comparison. FY2025 audit FY2025 return FY2023 original

FY2025 reports $5,019,578 government grants, $532,503 cash, $2,058,352 grants receivable and negative total net assets of $270,747. These indicate funding and working-capital vulnerability, not proof that a private gift creates new clinical capacity. Existing publicly financed childcare, home-visiting, Medicaid-related doula care and hospital support remain in the baseline. The audit and return differ in presentation of restricted balances, so the negative total—not a claim about freely spendable restricted resources—is used here.

Annual expenses

Organization-level spending, including programs, administration and fundraising. The research list averages three comparable, consecutive full fiscal years when available.

  • FY 2023: $7.0M; Northern Manhattan Perinatal Partnership Inc., EIN 13-3782555, 12-month period, Accrual whole-recipient gross expense; recognized in-kind resources included; prior-period adjustments excluded from current costs.. Source
  • FY 2024: $7.2M; Northern Manhattan Perinatal Partnership Inc., EIN 13-3782555, 12-month period, Later-return comparative only; original gross reconciliation unverified.. Source
  • FY 2025: $7.4M; Northern Manhattan Perinatal Partnership Inc., EIN 13-3782555, 12-month period, Accrual whole-recipient gross expense; recognized in-kind resources included; prior-period adjustments excluded from current costs.. Source

6. Sources

  1. FY2023 original IRS990. NMPP / IRS. Published: not stated; retrieved: 2026-09-14.
  2. FY2023 original IRS990ScheduleD. NMPP / IRS. Published: not stated; retrieved: 2026-09-14.
  3. FY2025 original IRS990. NMPP / IRS. Published: not stated; retrieved: 2026-09-14.
  4. FY2025 original IRS990ScheduleD. NMPP / IRS. Published: not stated; retrieved: 2026-09-14.
  5. Original FY2025 audit, visually inspected. NMPP / Allan S. Joseph CPA. Published: not stated; retrieved: 2026-09-14.
  6. 2024 year in review; charts visually verified. NMPP. Published: not stated; retrieved: 2026-09-14.
  7. Current Healthy Journey service scope. NMPP. Published: not stated; retrieved: 2026-10-07.
  8. Current financial-statement index. NMPP. Published: not stated; retrieved: 2026-09-14.
  9. Randomized prenatal home-visiting birth-outcome study. Lee et al. / American Journal of Preventive Medicine. Published: not stated; retrieved: 2026-09-14.
  10. Continuous labor-support review. Bohren et al. / Cochrane. Published: 2017-07-06; retrieved: 2026-09-14.
  11. Independent Citywide Doula Initiative audit. NYC Comptroller. Published: 2025-05-09; retrieved: 2026-09-14.
  12. Head Start randomized impact-study follow-up. US HHS / ACF. Published: not stated; retrieved: 2026-09-14.
  13. Community-centered maternal sepsis research, not an outcome evaluation. Richardson et al. / Seminars in Perinatology. Published: 2024-09-18; retrieved: 2026-09-14.
  14. Ordinary donation route. NMPP. Published: not stated; retrieved: 2026-09-14.
  15. Current Head Start service and contracted capacity. NMPP. Published: not stated; retrieved: 2026-10-07.
  16. Harlem Works training and job readiness. NMPP. Published: not stated; retrieved: 2026-10-07.